Good practices in non-clinical toxicology assessment to accelerate IND and NDA Submissions
SEPTEMBER 24, 2024
Continuous Flow Chemistry: A Game-Changer for Pharmaceutical Production
AUGUST 30, 2024
Revolutionizing Drug Discovery with AI: A Journey into the Future of Medicine
MAY 31, 2024
Navigating the Surge in Demand for Lipid Nano Carriers: Challenges and Future Perspectives
MAY 15, 2024
Challenges and winning strategies to develop an analytical method for Nitrosamines
MAY 14, 2024
A Brief Introduction to Click chemistry and Bioorthogonal chemistry
AUGUST 22, 2023
“Bathtub Chemistry” - Necessity and Aspects of Process Research
MAY 12, 2023
Neoantigen specific T cells for cellular cancer immunotherapy
JANUARY 11, 2022
Oligonucleotide as a novel class of therapeutic modality
JULY 02, 2021
Emerging Trends in Solid Phase Peptide Synthesis
FEBRUARY 23, 2021
Advantages of PROTACs over traditional drugs
FEBRUARY 08, 2021
Application of mPEGs in Drug Discovery and Development
JANUARY 04, 2021
Application & Manufacturing of High Potent Active Pharmaceutical Ingredient (HPAPI)
JANUARY 04, 2021
The influence of formulation development and its route of administration
JANUARY 04, 2021
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
Leaving already?
Don't forget to join us at
CPHI Worldwide 2023.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market